436 related articles for article (PubMed ID: 15455344)
1. JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats.
Wei M; Morimura K; Wanibuchi H; Shen J; Salim EI; Moku M; Hakoi K; Fukushima S
Int J Cancer; 2005 Jan; 113(3):354-8. PubMed ID: 15455344
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis.
Wei M; Morimura K; Wanibuchi H; Shen J; Doi K; Mitsuhashi M; Moku M; Salim EI; Fukushima S
Cancer Lett; 2003 Dec; 202(1):11-6. PubMed ID: 14643021
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
5. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Rao CV; Seibert K
Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
Tanaka T; Kojima T; Suzui M; Mori H
Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats.
Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS
Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412
[TBL] [Abstract][Full Text] [Related]
10. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
Yamamoto H; Kondo M; Nakamori S; Nagano H; Wakasa K; Sugita Y; Chang-De J; Kobayashi S; Damdinsuren B; Dono K; Umeshita K; Sekimoto M; Sakon M; Matsuura N; Monden M
Gastroenterology; 2003 Aug; 125(2):556-71. PubMed ID: 12891558
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
[TBL] [Abstract][Full Text] [Related]
12. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao CV; Hirose Y; Indranie C; Reddy BS
Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
[TBL] [Abstract][Full Text] [Related]
13. Effect of vanadium on colonic aberrant crypt foci induced in rats by 1,2 dimethyl hydrazine.
Kanna PS; Mahendrakumar CB; Chakraborty T; Hemalatha P; Banerjee P; Chatterjee M
World J Gastroenterol; 2003 May; 9(5):1020-7. PubMed ID: 12717849
[TBL] [Abstract][Full Text] [Related]
14. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.
Kawamori T; Uchiya N; Kitamura T; Ohuchida S; Yamamoto H; Maruyama T; Sugimura T; Wakabayashi K
Anticancer Res; 2001; 21(6A):3865-9. PubMed ID: 11911260
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of development of N,N'-dimethylhydrazine-induced rat colonic aberrant crypt foci by pre, post and simultaneous treatments with 24R,25-dihydroxyvitamin D3.
Salim EI; Wanibuchi H; Taniyama T; Yano Y; Morimura K; Yamamoto S; Otani S; Nishizawa Y; Morii H; Fukushima S
Jpn J Cancer Res; 1997 Nov; 88(11):1052-62. PubMed ID: 9439680
[TBL] [Abstract][Full Text] [Related]
20. A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters.
Furukawa F; Nishikawa A; Lee IS; Kanki K; Umemura T; Okazaki K; Kawamori T; Wakabayashi K; Hirose M
Int J Cancer; 2003 Apr; 104(3):269-73. PubMed ID: 12569549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
